Mankind Pharma
MANKIND · Pharma > Pharmaceuticals & Drugs Listing date: May 9, 2023

Stock Price vs Company Growth
1d
0.9%
1w
6.7%
1m
8.8%
3m
7.8%
6m
10.2%
1y
15.6%
all
19.8%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 2,242 0.9%
2,222
2,670
Company Overview

Sales
13,577 Cr
Growth: 20.1%
Profit after Tax
1,751 Cr
Growth: -7.5%
Large Cap
92,540 Cr
P/E: 52.4x
Industry P/E: 33.2x
Fundamentals

Sales (Cr) ₹ 13,577
Growth 20.1%
EBITDA 24.2%
P/S 6.8x
Dividend 0.0%
P/E 52.4x
Book Value ₹ 370
PEG Ratio 2.6x
ROE 12.7%
P/B 6.0x
Shareholding Pattern

Increase    Decrease    No change
Company Profile Detailed

The company is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.
Followers (2)